Insulin icodec: evolution or revolution in diabetes therapy?

Srikanth Bellary¹, Anthony H Barnett²

Affiliations

¹ College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK; Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: s.bellary@aston.ac.uk.
² Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

PMID: 37150185
DOI: 10.1016/S2213-8587(23)00125-0

Comment

Insulin icodec: evolution or revolution in diabetes therapy?

Srikanth Bellary et al. Lancet Diabetes Endocrinol. 2023 Jun.

. 2023 Jun;11(6):379-380.

doi: 10.1016/S2213-8587(23)00125-0. Epub 2023 May 4.

Authors

Srikanth Bellary¹, Anthony H Barnett²

Affiliations

¹ College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK; Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: s.bellary@aston.ac.uk.
² Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

PMID: 37150185
DOI: 10.1016/S2213-8587(23)00125-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

SB has received speaker fees and support for attending educational meetings from Eli Lilly and Boehringer Ingelheim and speaker fees from AstraZeneca. AHB declares no competing interests.

Comment on

Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial.
Philis-Tsimikas A, Asong M, Franek E, Jia T, Rosenstock J, Stachlewska K, Watada H, Kellerer M. Philis-Tsimikas A, et al. Lancet Diabetes Endocrinol. 2023 Jun;11(6):414-425. doi: 10.1016/S2213-8587(23)00093-1. Epub 2023 May 3. Lancet Diabetes Endocrinol. 2023. PMID: 37148899 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Insulin icodec: evolution or revolution in diabetes therapy?

Affiliations

Insulin icodec: evolution or revolution in diabetes therapy?

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical